Logotype for Implantica

Implantica (IMP) investor relations material

Implantica Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Implantica
Q3 2025 earnings summary31 Oct, 2025

Executive summary

  • Significant progress toward U.S. FDA approval for RefluxStop, with successful inspections, regulatory milestones, and positive FDA feedback.

  • RefluxStop addresses a large unmet need in acid reflux treatment, offering superior outcomes and fewer side effects compared to existing solutions.

  • NICE in the U.K. has approved RefluxStop for NHS public hospitals and severe GERD cases, expanding market potential.

  • U.S. market launch preparations are underway, including production scaling, new tools, and engagement with key opinion leaders.

  • RefluxStop generated significant enthusiasm at major U.S. conferences, reinforcing clinical credibility.

Financial highlights

  • Q3 net sales reached EUR 365,000, up 6% year-over-year; nine-month net sales were EUR 1,543,000, up 3%.

  • Adjusted gross margin was 93% in Q3 (down from 97%); nine-month margin improved to 94%.

  • Q3 operating loss was EUR 4.4 million, a 17% year-over-year decrease; nine-month EBIT loss reduced to EUR 13.13 million.

  • Net loss for Q3 was EUR 4.415 million; nine-month net loss was EUR 12.627 million.

  • Cash and short-term investments totaled EUR 53.3 million at quarter-end.

Outlook and guidance

  • Best estimate for U.S. FDA approval is the second half of Q1, with a well-defined path to U.S. market entry.

  • U.S. hospital contracts expected to take at least three months post-approval before surgeries can begin.

  • Expansion in the U.K. anticipated following NICE recommendation; regulatory submissions for Japan, Canada, and Brazil planned for 2026.

  • R&D and new product launches are on hold until after U.S. launch.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Implantica earnings date

Logotype for Implantica
Q4 202519 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Implantica earnings date

Logotype for Implantica
Q4 202519 Feb, 2026

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Implantica AG with headquarters in Horw/Luzern (Switzerland) is a company developing and distributing innovative solutions for reconstructive surgery. The company’s range of products includes implants based on the unique Zoladex® technology, which is used in a wide variety of applications such as industrial implants, biodegradable drug carriers and scaffolds. In addition Implantica provides best-in-class synthetic meshes for use in hernia repair procedures.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage